| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antiangiogenic Therapy Should be Considered Standard Treatment in the Adjuvant Therapy of Epithelial Ovarian Cancer
|
Rajappa, Senthil J.
|
|
2017
|
|
supplement-1 |
p. 3-7
|
article
|
| 2 |
Controversies in Gynaecologic Oncology
|
Maheshwari, Amita
|
|
2017
|
|
supplement-1 |
p. 1-2
|
article
|
| 3 |
Cytoreductive Surgery and HIPEC in the First-Line and Interval Time Points of Advanced Epithelial Ovarian Cancer
|
Kusamura, Shigeki
|
|
2017
|
|
supplement-1 |
p. 11-20
|
article
|
| 4 |
DNA Repair Defects for Therapy in Ovarian Cancer: The BRCA1/2 and PARP Inhibitor Story
|
Cyriac, Sunu Lazar
|
|
2017
|
|
supplement-1 |
p. 65-75
|
article
|
| 5 |
Germline Testing for Predisposition to Breast/Ovarian Cancer Should Only be Offered to Selected Patients with Epithelial Ovarian Cancer
|
Nag, Shona
|
|
2017
|
|
supplement-1 |
p. 31-36
|
article
|
| 6 |
Germline Testing for Predisposition to Ovarian/Breast Cancer Should be Routinely Recommended in all Patients with Invasive Epithelial Ovarian Cancer
|
Wheeler, Lindsay J.
|
|
2017
|
|
supplement-1 |
p. 27-30
|
article
|
| 7 |
Is There Any Difference in Platelets Indices Between Benign and Malignant Epithelial Tumors of the Ovary?
|
Nassiri, Setare
|
|
2017
|
|
supplement-1 |
p. 49-53
|
article
|
| 8 |
Ovarian Cancer: Bevacizumab as Adjuvant Treatment—Not Yet
|
Agarwal, Amit
|
|
2017
|
|
supplement-1 |
p. 9-10
|
article
|
| 9 |
Standardization of Patient Selection and Hyperthermic Intraperitoneal Chemotherapy Protocol for Peritoneal Surface Malignancy in Indian Patients
|
P, Somashekhar S.
|
|
2017
|
|
supplement-1 |
p. 55-63
|
article
|
| 10 |
Systematic Retroperitoneal (Pelvic and Para-aortic) Lymph Node Dissection Cannot be Routinely Recommended in All Patients of Clinically Early Endometrial Cancer
|
Goyal, Bhupesh K.
|
|
2017
|
|
supplement-1 |
p. 45-48
|
article
|
| 11 |
Systematic Retroperitoneal (Pelvic and Para-aortic) Lymph Node Dissection Should be Routinely Performed in Patients with Clinically Early Endometrial Cancer
|
Biswas, Manash
|
|
2017
|
|
supplement-1 |
p. 37-43
|
article
|
| 12 |
There is Currently no Role of HIPEC in Epithelial Ovarian Cancer in Routine Clinical Practice
|
Kulkarni, Yogesh
|
|
2017
|
|
supplement-1 |
p. 21-25
|
article
|
Journal description